Announce Date | 09/04/2025 |
EPS Normalized Actual | $0.07 (Beat by $0.01) |
EPS GAAP Actual | $0.07 (Beat by $0.01) |
Revenue Actual | $0.103676B |
Revenue Surprise | Beat by $103.676M |
Announce Date | 10/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.26777 |
EPS GAAP Estimate | $0.26777 |
Revenue Estimate | $0.133313715B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2027 | 0.69016 | 10.23 | 0.67463 | 0.70595 | 1 |
Oct 2026 | 1.03344 | 6.83 | 1.00854 | 1.05564 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.063 | -0.18791 | 0.103676B | -5.73% | -27.62M |
FQ2 2025 (Apr 2025) | -0.01 | -0.01 | 0.093958B | -13.95% | 93.96M |
FQ1 2025 (Jan 2025) | 0 | 0 | 0.086447B | -13.03% | 86.45M |
FQ4 2024 (Oct 2024) | 0.18 | 0.18 | 0.111482B | -7.82% | 111.48M |
FQ3 2024 (Jul 2024) | 0.0001 | 0.0001 | 0.109617B | -10.08% | 109.62M |
FQ2 2024 (Apr 2024) | 0.057 | 0.057 | 0.107062B | 100% | 107.06M |
FQ1 2024 (Jan 2024) | -0.0001 | -0.0001 | 0.097711B | 100% | 97.71M |
FQ4 2023 (Oct 2023) | 0 | 0 | 0.120204B | 100% | 120.2M |
FQ4 Announce Date
10/30/2025 (Pre-Market)
Consensus EPS Estimates
0.26777
Consensus Revenue Estimates
0.133313715B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0.25504 | -- | 0.24996 | 0.26005 | 1 |
FQ3 2027 (Jul 2027) | 0.23193 | -- | 0.22731 | 0.23649 | 1 |
FQ2 2027 (Apr 2027) | 0.14864 | -- | 0.14568 | 0.15156 | 1 |
FQ1 2027 (Jan 2027) | 0.054551 | -- | 0.05375344 | 0.05571394 | 1 |
FQ4 2026 (Oct 2026) | 0.344 | -- | 0.34044 | 0.3489 | 1 |
FQ3 2026 (Jul 2026) | 0.34046 | 81.5 | 0.33693 | 0.34531 | 1 |
FQ2 2026 (Apr 2026) | 0.22249 | 104.49 | 0.22019 | 0.22566 | 1 |
FQ1 2026 (Jan 2026) | 0.16609 | -- | 0.16609 | 0.16609 | 1 |
FQ4 2025 (Oct 2025) | 0.26777 | 32.78 | 0.265 | 0.27158 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0.12B | -- | 0.12B | 0.12B | 2 |
FQ3 2027 (Jul 2027) | 0.12B | -- | 0.12B | 0.12B | 2 |
FQ2 2027 (Apr 2027) | 0.11B | -- | 0.11B | 0.11B | 2 |
FQ1 2027 (Jan 2027) | 0.09B | -- | 0.09B | 0.1B | 1 |
FQ4 2026 (Oct 2026) | 0.14B | -- | 0.14B | 0.14B | 2 |
FQ3 2026 (Jul 2026) | 0.14B | 25.99 | 0.14B | 0.14B | 2 |
FQ2 2026 (Apr 2026) | 0.12B | 24.09 | 0.12B | 0.13B | 2 |
FQ1 2026 (Jan 2026) | 0.11B | 18.58 | 0.11B | 0.11B | 1 |
FQ4 2025 (Oct 2025) | 0.13B | 16.38 | 0.13B | 0.13B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
3
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.25091 | 0.063 | -0.18791 | -298.27% |
FQ2 2025 (Apr 2025) | -0.01 | -0.01 | 100% | |
FQ1 2025 (Jan 2025) | 0 | 0 | NAN% | |
FQ4 2024 (Oct 2024) | 0.18 | 0.18 | 100% | |
FQ3 2024 (Jul 2024) | 0.0001 | 0.0001 | 100% | |
FQ2 2024 (Apr 2024) | 0.057 | 0.057 | 100% | |
FQ1 2024 (Jan 2024) | -0.0001 | -0.0001 | 100% | |
FQ4 2023 (Oct 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | $0.13B | $0.1B | $-27.62M | -26.64% |
FQ2 2025 (Apr 2025) | $0B | $0.09B | $93.96M | 100% |
FQ1 2025 (Jan 2025) | $0B | $0.09B | $86.45M | 100% |
FQ4 2024 (Oct 2024) | $0B | $0.11B | $111.48M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.11B | $109.62M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.11B | $107.06M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.1B | $97.71M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.12B | $120.2M | 100% |